Abstract
Fusion genes involving MEF2D have recently been identified in precursor B-cell acute lymphoblastic leukemia, mutually exclusive of the common risk stratifying genetic abnormalities, although their true incidence and associated clinical characteristics remain unknown. We identified 16 cases of acute lymphoblastic leukemia and 1 of lymphoma harboring MEF2D fusions, including MEF2D-BCL9 (n=10), MEF2D-HNRNPUL1 (n=6), and one novel MEF2D-HNRNPH1 fusion. The incidence of MEF2D fusions overall was 2.4% among consecutive precursor B-cell acute lymphoblastic leukemia patients enrolled onto a single clinical trial. They frequently showed a cytoplasmic μ chain-positive pre-B immunophenotype, and often expressed an aberrant CD5 antigen. Besides up- and down-regulation of HDAC9 and MEF2C, elevated GATA3 expression was also a characteristic feature of MEF2D fusion-positive patients. Mutations of PHF6, recurrent in T-cell acute lymphoblastic leukemia, also showed an unexpectedly high frequency (50%) in these patients. MEF2D fusion-positive patients were older (median age 9 years) with elevated WBC counts (median: 27,300/ml) at presentation and, as a result, were mostly classified as NCI high risk. Although they responded well to steroid treat...Continue Reading
Citations
Jun 10, 2020·Hematological Oncology·Koshi AkahaneTakeshi Inukai
Oct 28, 2019·Cold Spring Harbor Perspectives in Medicine·Kathryn G Roberts, Charles G Mullighan
May 6, 2020·Genes, Chromosomes & Cancer·Kentaro OhkiUNKNOWN Tokyo Children's Cancer Study Group (TCCSG)
Feb 29, 2020·Blood Cancer Journal·Daiichiro HasegawaUNKNOWN Japan Association of Childhood Leukemia Study Group (JACLS)
Nov 30, 2019·Annals of Hematology·Jiewen SunXiang Zhang
Jun 17, 2020·Therapeutic Advances in Hematology·Seth E Karol, Ching-Hon Pui
Oct 24, 2020·Blood Advances·Hiroo UenoMasashi Sanada
Jan 6, 2021·Frontiers of Medicine·Jianfeng LiSaijuan Chen
Nov 23, 2020·Protein Expression and Purification·Zhiming ChenGuoyu Meng
Jan 28, 2021·Cancer Cell International·Minori TamaiTakeshi Inukai
Feb 12, 2021·Cancer Genetics·Matthew C HiemenzGordana Raca
Oct 16, 2020·Haematologica·Hiroto Inaba, Charles G Mullighan
Nov 26, 2020·Journal of Pediatric Hematology/oncology·Hee Jo BaekHoon Kook
May 6, 2021·Journal of Clinical Medicine·Hiroto Inaba, Ching-Hon Pui
Jun 18, 2021·Blood Cancer Journal·Xue ChenHongxing Liu
Jul 9, 2021·Biomarker Research·Francesca Maria OrlandellaPeppino Mirabelli
Jul 15, 2021·British Journal of Haematology·Kentaro OhkiUNKNOWN Japan Children’s Cancer Study Group (JCCG)
Aug 13, 2021·Frontiers in Oncology·Jason H Kurzer, Olga K Weinberg
Aug 9, 2021·The Journal of Molecular Diagnostics : JMD·Winnie Hui Ni ChinAllen Eng-Juh Yeoh
Aug 28, 2021·Cancers·Shawn H R LeeAllen E J Yeoh
Apr 26, 2021·Blood·Elisabeth PaiettaMark R Litzow
Dec 8, 2021·Proceedings of the National Academy of Sciences of the United States of America·Ga Hye Kim, Ilmin Kwon
Sep 22, 2021·Blood Advances·Zhenhua LiAllen Eng-Juh Yeoh